SCHEMBL13065732

SCHEMBL13065732

O=C(O)c1c2nc3ccccc3oc-2c(O)c(=O)c1-c1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.45
DHODH Q02127 11/20 0.44
LMNA P02545 3/20 0.40
PDE10A Q9Y233 1/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MITF O75030 1/20 0.39
GAA P10253 2/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ABCB1 P08183 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065731 0.92 DHODH (0.47) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL13065738 0.90 HPGD (0.42) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL13065735 0.89 LMNA (0.48) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL16784744 0.86 PDE10A (0.40) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL13065729 0.86 KDM4E (0.51) DHODHLMNAMAPTMEN1KMT2A
SCHEMBL13065740 0.86 LMNA (0.39) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL13065737 0.86 DHODH (0.39) DHODHLMNAPDE10AMAPTMEN1
SCHEMBL13065741 0.85 DHODH (0.47) MAPK14DHODHMAPTMEN1KMT2A
SCHEMBL13065589 0.83 DHODH (0.40) DHODHLMNAMAPTMEN1KMT2A
SCHEMBL13065601 0.81 KMT2A (0.43) DHODHMAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MAPK14 1817/4885DHODH 3278/4885LMNA 4171/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MAPK14 1817/4885DHODH 3278/4885LMNA 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.